Jacopo Pigozzo

12PUBLICATIONS
86CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 26, 2026
Neoadjuvant Therapy and the Evolving Management of Resectable Advanced Melanoma.

|Jun 26, 2026
Adjuvant Approaches in Fully Resected Stage III and IV Cutaneous Melanoma: Where Are We Now?

|Jun 12, 2026
Adjuvant Therapy for High-Risk Stage II Cutaneous Melanoma: Insights and Future Directions.

|May 27, 2026
New Perspectives and Open Issues in the Adjuvant and Neoadjuvant Treatment of Melanoma.

|Apr 21, 2026
MONETTE: A Randomized Phase II Study of Ceralasertib plus Durvalumab or Ceralasertib Monotherapy in Patients with Advanced Melanoma Resistant to PD-(L)1 Inhibition.

|Aug 28, 2025
Molecular Basis of BRAF Inhibitor Resistance in Melanoma: A Systematic Review.

Ilaria Cosci, Valentina Salizzato, Paolo Del Fiore

Pageof 2

Frequent Collaborators

4 joint publications

Paolo Fava

4 joint publications

Michele Del Vecchio

4 joint publications

Gabriele Roccuzzo

4 joint publications

Alessandro Minisini